Brief

The inspection report for Curium Pet France's pharmaceutical establishment at CHU Xavier Arnozan highlighted significant non-conformities and shortcomings. Notified on July 31, 2024, these issues included deficiencies in deviation management, insufficient complaint handling, qualification and maintenance failures, and delayed final review and certification of radiopharmaceutical products. The ANSM has issued a formal injunction to Curium Pet France, requiring them to address these issues within specified timeframes.

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies